Revenues, Recognition and Allowances (Tables)

6 Months Ended

Jun. 30, 2020

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenues

Net revenues for the three and six months ended June 30, 2020 and 2019 were as follows:

	Three months ended June 30,				Six months ended June 30,
	2020		2019		2020		2019
Company product sales	$	13,025	$	17,868	$	20,164	$	30,363
Contract manufacturing sales	310		388		507		930
Research and development services and other income	251		85		$	362	$	170
Revenue, net	$	13,586	$	18,341	$	21,033	$	31,463

Disaggregated information for the Company product sales revenue has been recognized in the accompanying unaudited interim Condensed Consolidated Statements of Operations and is presented below according to product type:

	Three months ended June 30,				Six months ended June 30,
Company Product Sales	2020		2019		2020		2019
Topical	$	8,776	$	12,937	$	14,156	$	21,969
Injectables	4,249		4,931		6,008		8,394
Total	$	13,025	$	17,868	$	20,164	$	30,363

Schedule of Accounts, Notes, Loans and Financing Receivable

The Company's adjustments for the deductions to gross product sales are as follows:

	Three months ended June 30,				Six months ended June 30,
	2020		2019		2020		2019
Gross product sales	$	36,717	$	39,322	$	59,883	$	66,736
Deduction to gross product sales:
Chargebacks and billbacks	17,551		11,826		29,506		22,712
Wholesaler fees for service	1,604		2,182		2,746		3,948
Sales discounts and other allowances	4,537		7,446		7,467		9,713
Total reduction to gross product sales	$	23,692	$	21,454	$	39,719	$	36,373
Company product sales, net	$	13,025	$	17,868	$	20,164	$	30,363